Header5

The simple corporate scheme behind massive US Brand Drug Prices

My 7-year whistleblower effort
"People Before Profits"

Short Path to the Truth

Straightforward Path: "Follow the Money"

Straightforward Questions to Industry Executives and Insiders 

  • To Pharma:
    • How much are you paying health insurer/PBMs?
    • How are you paying them?
      • Rebates vs. Fees vs. other ways?
      • Are the “pharma fees” tied to brand drug “sticker” prices?
    • What are you paying them these “pharma fees” for?
      • What “support services” are the PBMs providing for these fees?
      • How was the “fair” payment determined for these “services”, as is required by law? 
  • To Health Insurer/PBMs:
    • How much of your brand drug revenues/profits come from pharma?
      • From “rebates” vs. “pharma fees”?
    • How are these “pharma fees” paid?
      • Percent contracts tied to brand “sticker” prices?
      • What are you getting these “pharma fees” for?
        • What “support” work?
        • How is it a “fair” price?
      • In Part D, have these “pharma fees” been reported to the Government?
        • How much reported?
        • Where reported? 

Readily Accessible Investigative Data 

    • National pharma/PBM “fee” contracts
    • National Medicare Part D data
    • Detailed Part D documentation requirements
    • Clear Part D “pharma fee” legal requirements 

Nothing subtle regarding the extreme taxpayer harm and alleged "kickbacks" in these vast Whistleblower cases

    • 8-to-10-fold price increases
    • Vast increases in U.S. Pharma brand sales driven ONLY by these massive price increases, as use by physicians and patients has sharply declined
    • Massive “pharma fees” paid to health insurers/PBMs for doing a lot less legitimate work
    • Massive and unprecedented Whistleblower alleged taxpayer harm
      • In excess of $175 billion over the past decade-plus and ongoing
      • The largest alleged healthcare Whistleblower case in U.S. history, by a wide margin
    •  Severe and escalating patient, family, business and taxpayer harm across the nation
  • DOJ ADMITTED NOT DIRECTLY PURSUING THE CENTRAL KICKBACK AND OTHER KEY ALLEGATIONS IN ITS INVESTIGATION OF THESE WHISTLEBLOWER CASES 

Receive the Latest News

Your email is 100% safe.
Your privacy will be respected.
!
!
Something went wrong. Please check your entries and try again.
Scroll to Top